July 28, 2023 7:41am
Earnings season focus starts coming next week, so pay close attention to upcoming results that could affect your portfolio
My interpretation of the morning’s numbers is written to be informative; it’s built on what happened or will happen behind the headline today, not yesterday with a bit for tomorrow.
Subscription is coming, it’s not conscription but, an offer to join our collective of like-minded investors! Never leave an investor uninformed!
8:00 a.m. edition
Remember that overnight and pre-open actions in futures don't necessarily translate into actual trading in the coming day’s session. My interpretation of the morning’s numbers is written to be informative; it’s built on what will happen behind the headlines today, not tomorrow or yesterday
Dow futures are UP +0.29% or (+101 point), S&P futures are UP +0.49% or (+22 points) and NASDAQ futures are UP +0.88% or (+136 points) early in the pre-open – so far
Stock futures ticked up on Friday
European stocks were lower,
Asia pacific markets were mixed after Bank of Japan adjusted its stance on its yield curve control policy.
Henry’omics:
We need to more than consider the economic environment - rising rates and inflation to comprehend the micro re “our” universe of cell and gene therapy companies …
Momentum finally ran out on Thursday … indexes were dropping like a stone Thursday, as the Dow closed DOWN -237.40 points (-0.67%), the S&P closed DOWN -29.34 points (-0.64%) while the Nasdaq closed DOWN -77.18 points (-0.55%).
Economic Data Docket: employment costs, personal income, consumer spending and consumer sentiment.
- Personal consumption expenditures price index, a gauge of inflation that’s closely followed by the Federal Reserve. Economists expect that the core PCE gained 0.2% from the prior month and climbed 4.2%
Thursday’s (7/27) RegMed Investors’ (RMi) closing bell: “can share pricing slides be cured?” … https://www.regmedinvestors.com/articles/13052
Ebb and flow:
Q3: July - 1 holiday, 10 positive and 8 negative close
Q2/23 -
· June -1 Holiday, 9 negative and 11 positive closes
· May – 10 negative and 12 positive closes
· April ended - 1 holiday, 8 positive close and 11 negative closes
Q1/23 –-
· March – ended with 10 positive and 13 negative closes
· February – 1 holiday, 2 vacation, 7 negative and 8 positive closes
· January – 2 holidays, 11 positive and 9 negative closes
Companies in my headlights – It’s your decision; I provide ideas and context: INDICATIONS
I am parsing my participation … today as I’m squeamish about sector equities as earnings’ releases LPS (loss-per-share) numbers are soon to be struck!!
The BOTTOM LINE:
I follow the dictum, quoting Churchill that “short words are best, and the old words when short are best of all, as I try to keep it simple and short!
Stocks were setting up for a rebound on Friday, as investors prepared for the release of the Federal Reserve's favorite inflation measure and after a surprise Bank of Japan rate shift rattled markets.
Earnings are about to be ready for release – questions are …RUNWAYS on track for further downslides?
Few stocks are flashing buy, with sector names in particular facing a NO news period in the next few days, investors could NOT consider adding exposure.
There's nothing wrong with standing pat in the short run, holding on to sizable existing exposure.
I hate to be so negative or contrarian but, this is a NO spin zone and truth is its product; I can always be WRONG but, I am mostly EARLY!
Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.
All investments are subject to risks. Investors should consider investment objectives.
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives.
Regulation Analyst Certification (Reg AC): The research analyst primarily responsible for the content of this report certifies the following under Reg AC: I hereby certify that all views expressed in this report accurately reflect my personal views about the subject company or companies and its or their securities. I also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report.
Henry McCusker, the editor and publisher of RegMed Investors could hold or have positions securities referred to in this publication and he will NOTIFY investors of holdings.
